Stockscreener 앱 받기
1.69
10.46%
0.16
시간 외 거래:
1.71
0.02
+1.18%
Coherus Oncology Inc 주식(CHRS)의 최신 뉴스
Can Coherus Oncology Inc. (8C5) stock survive global slowdownDividend Hike & Growth Focused Entry Reports - ulpravda.ru
There's No Escaping Coherus Oncology, Inc.'s (NASDAQ:CHRS) Muted Revenues Despite A 27% Share Price Rise - simplywall.st
How Coherus Oncology Inc. (8C5) stock valuation compares with sectorOil Prices & Stepwise Swing Trade Plans - ulpravda.ru
Coherus publishes data on tagmokitug antibody for cancer treatment By Investing.com - Investing.com Nigeria
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Coherus (CHRS) Reports Promising Results for Anti-CCR8 Antibody in Cancer Treatment - GuruFocus
Coherus publishes data on tagmokitug antibody for cancer treatment - Investing.com India
Coherus Oncology Introduces Tagmokitug: Promising Results from CCR8-targeting Antibody Research - Quiver Quantitative
Coherus Oncology Announces Publication in Molecular Cancer - GlobeNewswire
What analysts say about Coherus Oncology Inc 8C5 stockMarket Insider Reports & Outstanding Growth Opportunities - earlytimes.in
Will Coherus Oncology Inc 8C5 stock outperform Dow Jones2025 Market Trends & Accurate Intraday Trading Signals - moha.gov.vn
Coherus Oncology (NASDAQ:CHRS) Share Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Coherus Oncology (NASDAQ:CHRS) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Coherus Oncology: A Two-Pronged March With Mid-2026 Implications (CHRS) - Seeking Alpha
Coherus Oncology, Inc.(NasdaqGM: CHRS) added to NASDAQ Biotechnology Index - marketscreener.com
Coherus Oncology (CHRS) price target increased by 13.33% to 5.78 - MSN
Coherus Oncology (CHRS) Price Target Increased by 13.33% to 5.78 - Nasdaq
Aug Shorts: How Coherus Oncology Inc. (8C5) stock valuation compares with sectorQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда
CEO Moves: How Coherus Oncology Inc. (8C5) stock valuation compares with sectorMarket Weekly Review & Risk Controlled Stock Pick Alerts - Улправда
Support Test: Can Coherus Oncology Inc. (8C5) stock survive global slowdownJuly 2025 Macro Moves & Smart Swing Trading Techniques - Улправда
Will Coherus Oncology Inc. (8C5) stock deliver stable dividends2025 Dividend Review & Breakout Confirmation Alerts - Улправда
CHRS: 2026 will be pivotal with major data readouts for novel immuno-oncology therapies - TradingView — Track All Markets
Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Coherus Oncology Earnings Notes - Trefis
LOQTORZI plus chemotherapy shows 31-month survival benefit in cancer study - Investing.com Australia
Coherus BioSciences stock jumps after positive cancer drug survival data By Investing.com - Investing.com UK
Coherus BioSciences stock jumps after positive cancer drug survival data - Investing.com
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma - The Manila Times
Coherus Oncology (CHRS) price target decreased by 11.77% to 5.10 - MSN
Why Coherus Oncology Inc. (8C5) stock stays on top picksTrade Risk Summary & Daily Technical Forecast Reports - Newser
Why global investors buy Coherus Oncology Inc. (8C5) stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Does Coherus Oncology Inc. (8C5) stock trade below intrinsic valueMarket Volume Summary & Community Consensus Stock Picks - Newser
Why Coherus Oncology Inc. (8C5) stock could rally strongly2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - Newser
Can Coherus Oncology Inc. (8C5) stock sustain free cash flow2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Coherus Oncology, Inc. (NASDAQ:CHRS) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - 富途牛牛
Can Coherus Oncology Inc. (8C5) stock hold up in economic slowdownTrade Risk Assessment & Fast Gain Stock Tips - Newser
How strong is Coherus Oncology Inc. (8C5) stock earnings growthAnalyst Downgrade & Safe Entry Zone Identification - Newser
Coherus Oncology (CHRS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Coherus Oncology Inc 8C5 a good long term investmentEconomic Impact on Stocks & Build Wealth Brick by Brick With Us - earlytimes.in
Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of "Hold" by Brokerages - MarketBeat
Will Coherus Oncology Inc. (8C5) stock top growth indexesJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Will Coherus Oncology Inc. (8C5) stock outperform value peersPortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com
Can Coherus Oncology Inc. (8C5) stock attract analyst upgradesJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Will Coherus Oncology Inc. (8C5) stock benefit from infrastructure billOil Prices & Technical Confirmation Trade Alerts - newser.com
0.90%
자본화:
|
볼륨(24시간):